Gooch & Housego (GHH) Trading update summary
Event summary combining transcript, slides, and related documents.
Trading update summary
11 Mar, 2026Trading performance
Second half trading was strong, with improved volumes in fibre optic modules for industrial markets as programs moved to volume production.
Aerospace and Defence saw revenue growth from precision optics and advanced sighting systems, with strong demand for ring laser gyro components.
Medical diagnostic instrument volumes increased due to customer program phasing, and medical laser deliveries began to recover as destocking ended.
Full year revenue and adjusted pre-tax profit are expected to be in line with market expectations.
Cash and financial position
Cash generation was strong in the second half, enabling a $3.9m reduction in borrowing.
Net debt (pre-IFRS 16) at year-end is expected to be slightly better than market expectations.
Order book and outlook
Order book at 30 September 2024 stood at £104.5m, down 5% organically from the prior year.
Declines in medical laser and industrial markets were partially offset by strong growth in Aerospace and Defence orders.
Early signs of recovery in medical laser and industrial markets, with sustained recovery expected next year.
Teams are focused on converting a healthy pipeline of new Aerospace and Defence prospects.
Latest events from Gooch & Housego
- Revenue up, profit down; strong order book and A&D/Life Sciences offset industrial weakness.GHH
H2 202411 Mar 2026 - Revenue and profit fell, but improved margins and a strong order book support a positive outlook.GHH
H1 202411 Mar 2026 - Acquisition creates a U.S. optical systems hub, boosting defense capabilities and growth potential.GHH
M&A announcement11 Mar 2026 - Revenue and profit surged, led by A&D and Life Sciences, with strong order cover for FY2025.GHH
H1 202511 Mar 2026 - Double-digit revenue and profit growth driven by A&D and acquisitions, with a record order book.GHH
H2 202511 Mar 2026 - Solid FY2024 results and acquisitions set the stage for growth in Life Sciences and Defence.GHH
Investor presentation11 Mar 2026 - Order book grew to £126.4M, driven by innovation, acquisitions, and operational improvements.GHH
AGM 2025 presentation11 Mar 2026 - Double-digit revenue growth and record order intake driven by A&D and new technology focus.GHH
AGM 2026 presentation11 Mar 2026 - Revenue delays impact FY2024, but strategic progress and FY2025 outlook remain strong.GHH
Trading update11 Mar 2026